Jin, D., Tran, N., Thomas, N., & Tran, D. D. (2019). Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity. PloS one, 14(10), e0223555. https://doi.org/10.1371/journal.pone.0223555
Chicago Style (17th ed.) CitationJin, Dan, Nguyen Tran, Nagheme Thomas, and David D. Tran. "Combining CDK4/6 Inhibitors Ribociclib and Palbociclib with Cytotoxic Agents Does Not Enhance Cytotoxicity." PloS One 14, no. 10 (2019): e0223555. https://doi.org/10.1371/journal.pone.0223555.
MLA (9th ed.) CitationJin, Dan, et al. "Combining CDK4/6 Inhibitors Ribociclib and Palbociclib with Cytotoxic Agents Does Not Enhance Cytotoxicity." PloS One, vol. 14, no. 10, 2019, p. e0223555, https://doi.org/10.1371/journal.pone.0223555.
Warning: These citations may not always be 100% accurate.